Reducing staff workload through patient involvement in oncology: A pilot study on self-disconnection of 5-fluorouracil elastomeric pumps at home.
[OBJECTIVES] The growing demand for home-based cancer therapy calls for efficient and patient-centred delivery models.
APA
Al Fartousi M, Susam MM, et al. (2026). Reducing staff workload through patient involvement in oncology: A pilot study on self-disconnection of 5-fluorouracil elastomeric pumps at home.. Annales pharmaceutiques francaises. https://doi.org/10.1016/j.pharma.2026.03.007
MLA
Al Fartousi M, et al.. "Reducing staff workload through patient involvement in oncology: A pilot study on self-disconnection of 5-fluorouracil elastomeric pumps at home.." Annales pharmaceutiques francaises, 2026.
PMID
41932359
Abstract
[OBJECTIVES] The growing demand for home-based cancer therapy calls for efficient and patient-centred delivery models. This study evaluates time savings and user satisfaction in patients receiving 5-fluorouracil (5-FU)-based chemotherapy who have been trained to disconnect their elastomeric pump at home.
[MATERIALS AND METHODS] In this six-month pilot, nine patients with colorectal or pancreatic cancer deemed capable by their oncologist or nurse were trained to self-disconnect their 5-FU pump and perform basic line care, with initial support from home care nurses. Satisfaction was assessed using questionnaires completed by patients, hospital oncology nurses and home care nurses.
[RESULTS] A total of 81 completed surveys were collected. Patients and home care nurses reported, respectively, time savings of 102 and 64mins per treatment cycle. Satisfaction rates remained stable when comparing disconnection by a nurse to self-disconnection.
[CONCLUSION] Self-disconnection of 5-FU elastomeric pumps by patients at home seems feasible and may reduce the burden on oncology staff while increasing patient autonomy.
[MATERIALS AND METHODS] In this six-month pilot, nine patients with colorectal or pancreatic cancer deemed capable by their oncologist or nurse were trained to self-disconnect their 5-FU pump and perform basic line care, with initial support from home care nurses. Satisfaction was assessed using questionnaires completed by patients, hospital oncology nurses and home care nurses.
[RESULTS] A total of 81 completed surveys were collected. Patients and home care nurses reported, respectively, time savings of 102 and 64mins per treatment cycle. Satisfaction rates remained stable when comparing disconnection by a nurse to self-disconnection.
[CONCLUSION] Self-disconnection of 5-FU elastomeric pumps by patients at home seems feasible and may reduce the burden on oncology staff while increasing patient autonomy.